Cargando…

Role of ocular cytology in vernal keratoconjunctivitis

BACKGROUND: Children with vernal keratoconjunctivitis (VKC) present symptoms that are similar to other ocular allergies, but more pronounced, and are controlled using topical steroids. To avoid excessive and prolonged use of topical steroid eye drops, over the past 20 years galenic eye drops of cycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruschi, Gaia, Ghiglioni, Daniele G., Osnaghi, Silvia, Rosazza, Chiara, Pires Marafon, Denise, Landi, Massimo, Marchisio, Paola G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016839/
https://www.ncbi.nlm.nih.gov/pubmed/31804769
http://dx.doi.org/10.1002/iid3.278
_version_ 1783497067725848576
author Bruschi, Gaia
Ghiglioni, Daniele G.
Osnaghi, Silvia
Rosazza, Chiara
Pires Marafon, Denise
Landi, Massimo
Marchisio, Paola G.
author_facet Bruschi, Gaia
Ghiglioni, Daniele G.
Osnaghi, Silvia
Rosazza, Chiara
Pires Marafon, Denise
Landi, Massimo
Marchisio, Paola G.
author_sort Bruschi, Gaia
collection PubMed
description BACKGROUND: Children with vernal keratoconjunctivitis (VKC) present symptoms that are similar to other ocular allergies, but more pronounced, and are controlled using topical steroids. To avoid excessive and prolonged use of topical steroid eye drops, over the past 20 years galenic eye drops of cyclosporine with a concentration of 1% to 2% and tacrolimus with a concentration of 0.1% have been introduced as a treatment for the severe and unresponsive forms. The main symptoms of VKC occur most frequently during the spring and tend to get worse during the summer, meaning that affected children tend to avoid exposure to sunlight. The aim of this study was to assess the most common cell types present in the conjunctiva of children with VKC, how ocular treatment can influence them, and whether affected children express a typical conjunctival pattern, which could be useful as a pathognomonic pattern of VKC, allowing us to study this rare eye disease. METHOD: This was a cohort study of 56 children, of whom 17 were not receiving any treatment at the time of testing, 14 were using steroid eye drops or had taken them in the previous 10 days, and 25 were treated with cyclosporine eye drops or tacrolimus eye drops 0.1%. RESULT: Children in group 1 (no topical therapy) express more epithelial cells, neutrophils, mast cells, eosinophils, and lymphocytes than the other two groups. CONCLUSION: Given the ease of performance, when conducting further longitudinal studies, the conjunctival cytology examination could be used, on the one hand, to diagnose VKC, especially when the clinical diagnosis is uncertain, and, on the other, to follow disease evolution and monitor the response to topical treatment.
format Online
Article
Text
id pubmed-7016839
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70168392020-03-06 Role of ocular cytology in vernal keratoconjunctivitis Bruschi, Gaia Ghiglioni, Daniele G. Osnaghi, Silvia Rosazza, Chiara Pires Marafon, Denise Landi, Massimo Marchisio, Paola G. Immun Inflamm Dis Original Research BACKGROUND: Children with vernal keratoconjunctivitis (VKC) present symptoms that are similar to other ocular allergies, but more pronounced, and are controlled using topical steroids. To avoid excessive and prolonged use of topical steroid eye drops, over the past 20 years galenic eye drops of cyclosporine with a concentration of 1% to 2% and tacrolimus with a concentration of 0.1% have been introduced as a treatment for the severe and unresponsive forms. The main symptoms of VKC occur most frequently during the spring and tend to get worse during the summer, meaning that affected children tend to avoid exposure to sunlight. The aim of this study was to assess the most common cell types present in the conjunctiva of children with VKC, how ocular treatment can influence them, and whether affected children express a typical conjunctival pattern, which could be useful as a pathognomonic pattern of VKC, allowing us to study this rare eye disease. METHOD: This was a cohort study of 56 children, of whom 17 were not receiving any treatment at the time of testing, 14 were using steroid eye drops or had taken them in the previous 10 days, and 25 were treated with cyclosporine eye drops or tacrolimus eye drops 0.1%. RESULT: Children in group 1 (no topical therapy) express more epithelial cells, neutrophils, mast cells, eosinophils, and lymphocytes than the other two groups. CONCLUSION: Given the ease of performance, when conducting further longitudinal studies, the conjunctival cytology examination could be used, on the one hand, to diagnose VKC, especially when the clinical diagnosis is uncertain, and, on the other, to follow disease evolution and monitor the response to topical treatment. John Wiley and Sons Inc. 2019-12-05 /pmc/articles/PMC7016839/ /pubmed/31804769 http://dx.doi.org/10.1002/iid3.278 Text en © 2019 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Bruschi, Gaia
Ghiglioni, Daniele G.
Osnaghi, Silvia
Rosazza, Chiara
Pires Marafon, Denise
Landi, Massimo
Marchisio, Paola G.
Role of ocular cytology in vernal keratoconjunctivitis
title Role of ocular cytology in vernal keratoconjunctivitis
title_full Role of ocular cytology in vernal keratoconjunctivitis
title_fullStr Role of ocular cytology in vernal keratoconjunctivitis
title_full_unstemmed Role of ocular cytology in vernal keratoconjunctivitis
title_short Role of ocular cytology in vernal keratoconjunctivitis
title_sort role of ocular cytology in vernal keratoconjunctivitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016839/
https://www.ncbi.nlm.nih.gov/pubmed/31804769
http://dx.doi.org/10.1002/iid3.278
work_keys_str_mv AT bruschigaia roleofocularcytologyinvernalkeratoconjunctivitis
AT ghiglionidanieleg roleofocularcytologyinvernalkeratoconjunctivitis
AT osnaghisilvia roleofocularcytologyinvernalkeratoconjunctivitis
AT rosazzachiara roleofocularcytologyinvernalkeratoconjunctivitis
AT piresmarafondenise roleofocularcytologyinvernalkeratoconjunctivitis
AT landimassimo roleofocularcytologyinvernalkeratoconjunctivitis
AT marchisiopaolag roleofocularcytologyinvernalkeratoconjunctivitis